Posts

Showing posts with the label Diabetic Foot Ulcer (DFU)

Diabetic Foot Ulcer (DFU) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Diabetic Foot Ulcer (DFU) Market Outlook Thelansis’s “Diabetic Foot Ulcer (DFU) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Diabetic Foot Ulcer (DFU) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s ...

Diabetic Foot Ulcer (DFU) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Diabetic Foot Ulcer (DFU) Market Outlook Thelansis’s “Diabetic Foot Ulcer (DFU) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Diabetic Foot Ulcer (DFU)   treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Diabetic Foot Ulcer (DFU) Overview Diabetic foot ulcers (DFUs) are a severe complication of diabetes mellitus and often lead to lower extremity amputation. The most common causes of DFUs are neuropathy, deformity, trauma, high plantar pressures, and peripheral arterial disease. DFUs are classified into different grades using the Wagner classification system, with Grade 0 being the least severe and Grade V being the most severe...

Diabetic Foot Ulcer (DFU) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Diabetic foot ulcers (DFUs) are a severe complication of diabetes mellitus and often lead to lower extremity amputation. The most common causes of DFUs are neuropathy, deformity, trauma, high plantar pressures, and peripheral arterial disease. DFUs are classified into different grades using the Wagner classification system, with Grade 0 being the least severe and Grade V being the most severe. Another classification system, the PEDIS system, considers perfusion, extent/size, depth/tissue loss, infection, and sensation. The PEDIS classification is highly relevant to the development of DFUs. The most common laboratory investigations done during the evaluation of a DFU include fasting blood sugar, glycated hemoglobin levels, complete metabolic panel, complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). The prognosis for DFUs is good if they are identified early and treated promptly. However, delays in care can lead to severe complications, such as...

Diabetic Foot Ulcer (DFU) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Foot ulcers are a significant complication of diabetes mellitus and frequently precede lower-extremity amputation. The most frequent underlying etiologies are neuropathy, deformity, trauma, high plantar pressures, and peripheral arterial disease. ·        Based on Wagner classification DFU is classified into Grade 0 to grade V. The PEDIS classification system is divided into five categories, Perfusion, Extent/size, Depth/tissue loss, Infection, and Sensation. The classification of PEDIS is highly relevant to the pathogenesis and development of DFU. ·        The prevalence of diabetic ulcer patients in the United States is 15-20%, and the risk of amputation is 15-46 more than non-DM patients. Thelansis’s “Diabetic Foot Ulcer (DFU) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, compet...

Diabetic Foot Ulcer (DFU) – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030

Image
Foot ulcers are a significant complication of diabetes mellitus and often precede lower-extremity amputation. The most frequent underlying etiologies are neuropathy, trauma, deformity, high plantar pressures, and peripheral arterial disease. ·        Based on Wagner classification DFU is classified into Grade 0 to grade V. The PEDIS classification system is divided also into 5 categories, Perfusion, Extent/size, Depth/tissue loss, Infection, and Sensation. The classification of PEDIS is highly relevant to the pathogenesis and development of DFU. ·        The treatments of diabetic ulcers consist of determining and repairing the underlying cause of the ulcer, good wound care, and prevention of ulcer recurrence. ·        DFU therapy includes necrotomy/debridement, reducing the load/pressure on the offensive area, manage the infection by diagnosing the type of bacteria. ·     ...